Although cancer-related fatigue (CRF) has gained increased attention in the past decade, therapy remains a challenge. Treatment programs are more likely to be effective if the needs and interests of the persons involved are well represented. | Experiences and views of different key stakeholders on the feasibility of treating cancer-related fatigue